Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$8.8 - $16.0 $0 - $0
0 Closed
0 $0
Q3 2021

Jan 10, 2025

BUY
$15.23 - $21.72 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021

BUY
$15.23 - $21.72 $0 - $0
0 New
0 $0
Q2 2021

Jan 10, 2025

BUY
$17.8 - $23.5 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021

BUY
$17.8 - $23.5 $0 - $0
0 New
0 $0
Q1 2021

Jan 10, 2025

BUY
$17.18 - $22.6 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021

BUY
$17.18 - $22.6 $0 - $0
0 New
0 $0
Q4 2020

Jan 10, 2025

BUY
$11.5 - $17.96 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021

BUY
$11.5 - $17.96 $0 - $0
0 New
0 $0

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $738M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.